The clinical spectrum of COVID-19–associated cutaneous manifestations: An Italian multicenter study of 200 adult patients - 10/04/21
, Giovanni Genovese, MD a, b, Chiara Moltrasio, MRes a, c, Valeria Gaspari, MD d, Pamela Vezzoli, MD e, Vincenzo Maione, MD f, Cosimo Misciali, MD d, Paolo Sena, MD e, Annalisa Patrizi, MD d, Annamaria Offidani, MD g, Pietro Quaglino, MD h, Renato Arco, MSc i, Marzia Caproni, MD j, Miriam Rovesti, MD k, Giorgio Bordin, MD l, Sebastiano Recalcati, MD m, Concetta Potenza, MD n, Claudio Guarneri, MD o, Gabriella Fabbrocini, MD p, Carlo Tomasini, MD q, Mariarita Sorci, MD r, Maurizio Lombardo, MD s, Paolo Gisondi, MD t, Andrea Conti, MD u, Giovanni Casazza, PhD v, Ketty Peris, MD w, x, Piergiacomo Calzavara-Pinton, MD f, Emilio Berti, MD a, bthe
Italian Skin COVID-19 Network of the Italian Society of Dermatology and Sexually Transmitted Diseases
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
COVID-19 is associated with a wide range of skin manifestations.
Objective |
To describe the clinical characteristics of COVID-19–associated skin manifestations and explore the relationships among the 6 main cutaneous phenotypes and systemic findings.
Methods |
Twenty-one Italian Dermatology Units were asked to collect the demographic, clinical, and histopathologic data of 200 patients with COVID-19–associated skin manifestations. The severity of COVID-19 was classified as asymptomatic, mild, moderate, or severe.
Results |
A chilblain-like acral pattern was significantly associated with a younger age (P < .0001) and, after adjusting for age, significantly associated with less severe COVID-19 (P = .0009). However, the median duration of chilblain-like lesions was significantly longer than that of the other cutaneous manifestations taken together (P < .0001). Patients with moderate/severe COVID-19 were more represented than those with asymptomatic/mild COVID-19 among the patients with cutaneous manifestations other than chilblain-like lesions, but only the confluent erythematous/maculo-papular/morbilliform phenotype was significantly associated with more severe COVID-19 (P = .015), and this significance disappeared after adjustment for age.
Limitations |
Laboratory confirmation of COVID-19 was not possible in all cases.
Conclusions |
After adjustment for age, there was no clear-cut spectrum of COVID-19 severity in patients with COVID-19–related skin manifestations, although chilblain-like acral lesions were more frequent in younger patients with asymptomatic/pauci-symptomatic COVID-19.
Le texte complet de cet article est disponible en PDF.Key words : coronavirus, COVID-19, infection, skin manifestations, SARS-CoV-2
Abbreviations used : CI, IQR, OR, SARS-CoV-2
Plan
| Drs Calzavara-Pinton and Berti contributed equally to this article. |
|
| Funding sources: None. |
|
| IRB approval status: Reviewed and approved by all participating sites and the IRB of the principal investigator's center (Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan: protocol no. 464_2020). |
|
| Reprints not available from the authors. |
Vol 84 - N° 5
P. 1356-1363 - mai 2021 Retour au numéro
Article précédent
- Long-term use of spironolactone for acne in women: A case series of 403 patients
- Vaibhav Garg, Juliana K. Choi, William D. James, John S. Barbieri
- A case series: 3-dimensional computed tomographic study of the superior orbital vessels: Superior orbital arcades and their relationships with the supratrochlear artery and supraorbital artery
- Zhi-Feng Liao, Wei-Jin Hong, Li-Yao Cong, Cheng-En Luo, Wen-Feng Zhan, Jia-Qia Ke, Sheng-Kang Luo
Bienvenue sur EM-consulte, la référence des professionnels de santé.